Estrogen insensitivity syndrome: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
[[File:Protein_ESR1_PDB_1a52.png|thumb|right|Structure of the estrogen receptor alpha (ESR1) protein.]] | [[File:Protein_ESR1_PDB_1a52.png|thumb|right|Structure of the estrogen receptor alpha (ESR1) protein.]] | ||
'''Estrogen Insensitivity Syndrome''' is a rare genetic condition characterized by the body's inability to respond to [[estrogen]], a key hormone in the development and regulation of the female reproductive system and secondary sexual characteristics. This condition is caused by mutations in the [[estrogen receptor]] gene, leading to a non-functional receptor that cannot bind estrogen effectively. | '''Estrogen Insensitivity Syndrome''' is a rare genetic condition characterized by the body's inability to respond to [[estrogen]], a key hormone in the development and regulation of the female reproductive system and secondary sexual characteristics. This condition is caused by mutations in the [[estrogen receptor]] gene, leading to a non-functional receptor that cannot bind estrogen effectively. | ||
| Line 10: | Line 7: | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Individuals with estrogen insensitivity syndrome typically present with symptoms of estrogen deficiency despite normal or elevated levels of circulating estrogen. In females, this may include: | Individuals with estrogen insensitivity syndrome typically present with symptoms of estrogen deficiency despite normal or elevated levels of circulating estrogen. In females, this may include: | ||
* Lack of breast development | * Lack of breast development | ||
* Primary [[amenorrhea]] | * Primary [[amenorrhea]] | ||
* Infertility | * [[Infertility]] | ||
* Osteoporosis | * [[Osteoporosis]] | ||
In males, the condition may present with: | In males, the condition may present with: | ||
| Line 31: | Line 25: | ||
== Management == | == Management == | ||
Management of estrogen insensitivity syndrome is primarily supportive and symptomatic. Hormone replacement therapy may be considered, although its effectiveness is limited due to the receptor's insensitivity. Management of osteoporosis and other complications is crucial. | Management of estrogen insensitivity syndrome is primarily supportive and symptomatic. Hormone replacement therapy may be considered, although its effectiveness is limited due to the receptor's insensitivity. Management of osteoporosis and other complications is crucial. | ||
Revision as of 18:39, 21 February 2025
Estrogen Insensitivity Syndrome is a rare genetic condition characterized by the body's inability to respond to estrogen, a key hormone in the development and regulation of the female reproductive system and secondary sexual characteristics. This condition is caused by mutations in the estrogen receptor gene, leading to a non-functional receptor that cannot bind estrogen effectively.
Pathophysiology
The syndrome results from mutations in the ESR1 gene, which encodes the estrogen receptor alpha. This receptor is crucial for mediating the effects of estrogen in various tissues, including the breast, uterus, and bone. In individuals with estrogen insensitivity syndrome, the receptor is unable to bind estrogen, leading to a lack of estrogenic effects in the body.
Clinical Presentation
Individuals with estrogen insensitivity syndrome typically present with symptoms of estrogen deficiency despite normal or elevated levels of circulating estrogen. In females, this may include:
- Lack of breast development
- Primary amenorrhea
- Infertility
- Osteoporosis
In males, the condition may present with:
- Lack of pubertal development
- Gynecomastia
- Infertility
Diagnosis
Diagnosis of estrogen insensitivity syndrome involves a combination of clinical evaluation, hormonal assays, and genetic testing. Elevated levels of circulating estrogen with a lack of expected physiological response suggest the condition. Genetic testing can confirm mutations in the ESR1 gene.
Management
Management of estrogen insensitivity syndrome is primarily supportive and symptomatic. Hormone replacement therapy may be considered, although its effectiveness is limited due to the receptor's insensitivity. Management of osteoporosis and other complications is crucial.
Related Pages
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
